Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Us2.ai and Ventripoint integrated into Ascend's Gen3Echo 🚀
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(12)
•••
Comment by jopatcloon Aug 29, 2024 9:21am
44 Views
Post# 36200953

RE:RE:Us2.ai and Ventripoint integrated into Ascend's Gen3Echo 🚀

RE:RE:Us2.ai and Ventripoint integrated into Ascend's Gen3Echo 🚀
Interesting post Yesterday  Hugh This afternoon I am travelling to London for introductory meetings with potential collaborators and industry partners who are attending the 2024 ESC Congress.Maybe some news??
Us2.ai 1 week ago Us2.ai at #ESCCongress 2024
Bringing the future of hashtag#Echocardiography and hashtag#trials to ESC Congress London Solution for Core Lab
Core Lab Applications
Elevate your Core Lab Research with AI-Echo precision and automate your workflow with our unique custom solution: US2.CloudLab
US2.AI provides innovative solutions, transforming how trials are conducted ( Now remember health Canada has approved us, FDA won’t be far behind. FDA V4.0 and Sales at any time now Insiders know!)
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities